The global agentic AI in healthcare market is poised for rapid expansion, with an anticipated CAGR of 35–40% through 2030. This growth is driven by rising demand for personalized healthcare, advances in AI technologies, and the industry’s shift toward preventive care and precision diagnostics. Agentic AI—defined as autonomous systems capable of decision-making without human intervention—is transforming key healthcare functions, including treatment optimization, patient monitoring, drug discovery, and chronic disease management. By analyzing large datasets and delivering real-time, patient-specific insights, agentic AI enables a shift from reactive to proactive healthcare models, addressing workforce shortages while improving efficiency and outcomes.
Technological innovation is a core driver behind this trend, with advancements in machine learning, natural language processing, and big data analytics enhancing AI’s ability to interpret and act on complex medical information. As these capabilities mature, agentic AI is being adopted across diverse healthcare segments—from diagnostics and clinical decision support to administrative automation and virtual health assistants. The market is highly competitive, featuring major players such as Microsoft, NVIDIA, Amazon Web Services, IBM, Google DeepMind, and Hippocratic AI. Companies are pursuing product development, strategic alliances, and geographic expansion to gain an edge. Medi-Tech Insights’ report segments the market by offering, application, end user, and region, offering a detailed forecast through 2030.